Mifepristone (generic), Mifeprex, RU-486 Newswire (Page 11)

Mifepristone (generic), Mifeprex, RU-486 Newswire (Page 11)

Comprehensive Real-Time News Feed for Mifepristone (generic), Mifeprex, RU-486. (Page 11)

Results 201 - 220 of 694 in Mifepristone (generic), Mifeprex, RU-486

  1. Planned Parenthood Ottawa advocating for easier access to abortion pillRead the original story w/Photo

    Mar 12, 2017 | CBC News

    Planned Parenthood Ottawa says an abortion pill called Mifegymiso, which has been legal to prescribe since July 2016, is still to hard for many women to access. Mifegymiso is a two-step abortion process, which involves taking separate medications: mifepristone blocks the hormone progesterone, while misoprostol induces a miscarriage.


  2. Duffy still making false claims on Planned ParenthoodRead the original story w/Photo

    Mar 10, 2017 | The Oak Ridge Observer

    The states that wish to redirect the money to clinics that can offer a pregnant woman a broad array of services-including prenatal care - should be able to do so. "Planned Parenthood takes lives", said Peter Wolfgang, executive director of the Family Institute of CT.


  3. Legislature Live: Read what doctors may have to tell women seeking a medically-induced abortionRead the original story w/Photo

    Feb 7, 2017 | Salt Lake Tribune

    It's the final day of the Legislature, the last chance for bills to pass through the gauntlet of lawmakers and be sent to the governor - or die on the floor. Salt Lake Tribune reporters Lee Davidson, Benjamin Wood and others will be bringing you the latest updates from the Hill all day.


  4. Abortion pill Mifegymiso now available at Winnipeg hospitalRead the original story w/Photo

    Mar 9, 2017 | GlobalNews

    The pill is a new drug that's slowly being released across the country. There is now one practitioner at the Women's Hospital at Health Science Centre who can administer the drug, Bronwyn Penner-Holigroskiwith the Winnipeg Regional Health Authority said.


  5. Abortion pill available at HSC in Winnipeg - but patients will payRead the original story w/Photo

    Mar 9, 2017 | CBC News

    The abortion pill Mifegymiso is now available in Manitoba, but the approximately $350 treatment is not currently covered by any drug plans or Pharmacare. A spokesperson for the Winnipeg Regional Health Authority confirmed Wednesday the drug is now available at Health Sciences Centre's Women's Hospital. 4 comments

  6. House Panel Approves Bill Legalizing Telemedicine Abortion PillsRead the original story w/Photo

    Mar 8, 2017 | PR Log

    March 8, 2017 - PRLog -- Even though no Idaho healthcare professionals partake in telemedicine to perform pregnancy terminations, which are administrated by taking Mifepristone & Misoprostol [ MTP Kit ] pills, the legislature passed 2 laws to ban its use for abortion in 2015, one specifically targeting the procedure, meanwhile the other is a part of a larger bill expanding use of telemedicine in general. One of America's biggest reproductive healthcare center of the Hawaiian Islands and Great Northwest had sued the states' in December of 2015 to reverse the laws and the state hasn't imposed the ban since Idaho's Attorney General's office agreed in the spring of 2016 to suspend the ban in the meantime the case made its way through courts.


  7. Abortion pill rollout deeply flawed: MallickRead the original story w/Photo

    Mar 6, 2017 | InsideHalton.com

    Mifegymiso remains hard for doctors to prescribe, difficult for pharmacists to dispense and is too distant and costly for many vulnerable women Why is it taking so long for the abortion pill to become commonplace in Canada, just like any other prescribed medication? It is not a special drug in any sense. It works as expected.


  8. Abortion pill Mifegymiso starts to arrive in SaskatchewanRead the original story w/Photo

    Mar 6, 2017 | GlobalNews

    WATCH ABOVE: While not yet widely available in Saskatchewan, 25 doctors and pharmacists in the province have signed up for training on the use of the abortion pill Mifegymiso. As Meaghan Craig reports, the pill can only be prescribed by health care professionals who have been registered and trained in its use.


  9. Ipas issues 2017 updates to clinical abortion recommendationsRead the original story

    Mar 3, 2017 | PressReleasePoint

    Ipas's annual release of Clinical Updates in Reproductive Health continues to offer the most up-to-date, evidence-based clinical recommendations on comprehensive abortion care in English and Spanish , with new topics and resources added for 2017. As an organization offering technical assistance to health systems, Ipas promotes evidence-based clinical practice and the right to high-quality health care for all people-and uses the Clinical Updates to further these priorities.


  10. Bill telling women abortion can be halted introducedRead the original story w/Photo

    Mar 1, 2017 | Albany Times Union

    An Idaho Senate panel introduced legislation on Wednesday requiring the state to distribute information telling women that a drug-induced abortion may be halted halfway through, despite physicians warning there's not enough science backing up that claim. Sen. Lori Den Hartog , a Republican from Meridian, says the goal is to give women as much information as possible before deciding to have an abortion.


  11. GOP-heavy panel backs abortion-reversal bill, saying intent is 'informed consent'Read the original story w/Photo

    Mar 1, 2017 | Deseret News

    Rep. Keven Stratton, R-Orem, insists that his bill requiring doctors to tell their patients that drug-induced abortion can be reversed midway through the process is neither anti-abortion nor pro-abortion rights. Stratton's HB141 would require doctors to tell their patients about the process of a chemical abortion, as well as the odds of its success and the potential for a chemical reversal before the process is complete.


  12. Overregulation is forcing women to have late-term abortionsRead the original story w/Photo

    Feb 28, 2017 | Los Angeles Times

    In my experience as an OB-GYN, when women decide to end a pregnancy, they want to obtain an abortion quickly. One good reason is the simple fact that early abortion is associated with a lower risk of medical complications compared to later abortion.


  13. Why a Team of Experts Wants the FDA to Ease Abortion Pill RestrictionsRead the original story w/Photo

    Feb 27, 2017 | Self.com

    According to a group of medical experts, it's time to loosen the Food and Drug Administration's restrictions on one of the drugs collectively known as the " As a result, people can't purchase it with a doctor's prescription at a drugstore or order it online, per the . Instead, they can only obtain it from a certified prescriber at a clinic, doctor's office, or hospital, and they must verify that they've been briefed on how to use it properly.


  14. Bill requires doctors to follow script on stopping drug-induced abortionRead the original story w/Photo

    Feb 24, 2017 | KSL-TV

    Questions about whether Stratton had inserted his political leanings into the bill went unanswered Friday during debate on the House floor, but the legislation easily advanced with a 56-13 vote. HB141 next goes to the Senate for its consideration.


  15. An Abortion 'Reversal' Bill Is Making the Rounds in IndianaRead the original story w/Photo

    Feb 24, 2017 | Self.com

    "reversal" bill was approved by a panel in the Indiana House of Representatives on Tuesday. Known as House Bill 1128, the controversial bill would require abortion providers to give people seeking the acknowledges that fact, noting that women seeking an abortion should be given a form with websites and telephone numbers for help, along with "a statement that no medical study has confirmed that an abortion may be reversed after taking an abortion-inducing drug."


  16. The FDA's Restrictions on the Abortion Pill May Be Harming WomenRead the original story w/Photo

    Feb 24, 2017 | Teen Vogue

    If you're seeking an abortion, there are two different options depending on how far along you are in your pregnancy, according to Planned Parenthood. There's the in-clinic abortion , which is a medical procedure to end your pregnancy.


  17. Are restrictions on the 'abortion pill' politics or science?Read the original story w/Photo

    Feb 24, 2017 | Los Angeles Times

    Mifepristone, half of the two-pill regimen that induces abortion medically, can be dispensed only under FDA restrictions, which a panel calls unwarranted. Mifepristone, half of the two-pill regimen that induces abortion medically, can be dispensed only under FDA restrictions, which a panel calls unwarranted.


  18. Guatemala blocks entry to Dutch ship providing abortionsRead the original story w/Photo

    Feb 24, 2017 | Channelnewsasia.com

    Guatemala's army detained a boat carrying a supply of abortion pills on Thursday and prevented it from picking up women seeking to end their pregnancies, saying the move was prohibited by the country's constitution. A guard faces members of Women on Waves, a Dutch non-profit that provides abortion services beyond the territorial waters of countries where abortion is illegal, in Puerto de San Jose, Guatemala February 23, 2017.


  19. Guatemalan army blocks Dutch abortion ship from dockingRead the original story w/Photo

    Feb 23, 2017 | Washington Examiner

    A Dutch boat that offers abortion pills to women in countries where the procedure is illegal was taken into custody by army officials in Guatemala on Thursday after it tried to pick up people seeking the services. The Guatemalan military detained the boat, including some of the Women on Waves crew members, near the Port of San Jose, according to a spokeswoman for the nonprofit.


  20. Activists aghast as FDA asked to give abortion pill to pharmaciesRead the original story w/Photo

    Feb 23, 2017 | Washington Examiner

    Activists who oppose abortion were horrified to hear that a group of doctors and public health experts urged the Food and Drug Administration to make a later term medical abortion pill available to pharmacies. Ten co-authors published a commentary on Wednesday in the New England Journal of Medicine.